Screener
Pacira BioSciences, Inc. PCRX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Income before income taxes | 4,998 | 8,706 |
| Income tax expense | (2,082) | (3,894) |
| Net income | $2,916 | $4,812 |
| Net income per common share: | ||
| Basic and diluted net income per common share | $0.07 | $0.10 |
| Weighted average common shares outstanding: | ||
| Basic | 40,461 | 46,275 |
| Diluted | 40,910 | 46,526 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s shares (diluted)?
- Pacira BioSciences, Inc. (PCRX) reported shares (diluted) of 40.9M in Q1 2026.
- How has Pacira BioSciences, Inc.'s shares (diluted) changed year-over-year?
- Pacira BioSciences, Inc.'s shares (diluted) decreased by 12.1% year-over-year, from 46.5M to 40.9M.
- What is the long-term trend for Pacira BioSciences, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s shares (diluted) has grown at a -0.2% compound annual growth rate (CAGR), from 182.7M to 181.5M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Pacira BioSciences, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude